Literature DB >> 26189073

Impact of percutaneous dilatational tracheostomy in brain injured patients.

Jan Nils Kuechler1, Abdulkareem Abusamha1, Sandra Ziemann1, Volker Martin Tronnier1, Jan Gliemroth2.   

Abstract

OBJECTIVE: Tracheostomy is an established method in the airway management of critically ill patients with traumatic and non-traumatic brain injuries. High priority in the treatment of those patients is to protect vulnerable brain tissue. While bedside percutaneously dilatative tracheostomy (PDT) technique is increasingly used, there is disagreement about the harms of this intervention for the damaged brain. Therefore, discussions about the safety of tracheostomy in those patients must consider direct and indirect cerebral parameters.
METHODS: We examined a series of 289 tracheostomies regarding vital signs, respiratory and intracranial parameters in a retrospective study. Complications were recorded and risk factors for a complicated scenario statistically determined.
RESULTS: Severe complications were rare (1/289). Arterial hypotension occurred in 3 of 289 cases with a systolic blood pressure below 90mmHg. We had two patients (0.5%) with transient hypoxia, but 43 cases (15%) of severe hypercapnia during PDT. Invasive measurement of brain tissue oxygen tension (PBrO2) ruled out any cerebral hypoxia during the procedure in 39 available cases. Intracranial pressure (ICP) rose temporarily in 24% of the cases. Cerebral perfusion pressure (CPP) however remained unaffected. Surgery time and hypercapnia are capable risk factors for intraoperative ICP elevation. There is no significant difference in intraoperative ICP rises between disease entities.
CONCLUSION: PDT is a safe procedure for the most common neurosurgical diseases, even for patients with respiratory insufficiency. Shortening surgical time seems to be the most important factor to avoid ICP increase.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain tissue oxygen tension; Cerebral perfusion pressure; Intracranial pressure; Percutaneously dilatative tracheostomy

Mesh:

Year:  2015        PMID: 26189073     DOI: 10.1016/j.clineuro.2015.07.007

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  What's new in intensive care: tracheostomy-what is known and what remains to be determined.

Authors:  José Aquino Esperanza; Paolo Pelosi; Lluís Blanch
Journal:  Intensive Care Med       Date:  2019-08-26       Impact factor: 17.440

2.  The Timing of Tracheostomy and Outcomes After Aneurysmal Subarachnoid Hemorrhage: A Nationwide Inpatient Sample Analysis.

Authors:  Hormuzdiyar H Dasenbrock; Robert F Rudy; William B Gormley; Kai U Frerichs; M Ali Aziz-Sultan; Rose Du
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

3.  Bronchoscopy versus an endotracheal tube mounted camera for the peri-interventional visualization of percutaneous dilatational tracheostomy - a prospective, randomized trial (VivaPDT).

Authors:  Jörn Grensemann; Lars Eichler; Sophie Kähler; Dominik Jarczak; Marcel Simon; Hans O Pinnschmidt; Stefan Kluge
Journal:  Crit Care       Date:  2017-12-29       Impact factor: 9.097

4.  Impact of bedside percutaneous dilational and open surgical tracheostomy on intracranial pressure, pulmonary gas exchange, and hemodynamics in neurocritical care patients.

Authors:  Martin Kieninger; Martin Windorfer; Christoph Eissnert; Nina Zech; Sylvia Bele; Florian Zeman; Elisabeth Bründl; Bernhard Graf; Holger Künzig
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Semi-surgical percutaneous dilatational tracheostomy vs. conventional percutaneous dilatational tracheostomy: A prospective randomized trial.

Authors:  Novin Nikbakhsh; Fatemeh Amri; Mahmood Monadi; Parviz Amri; Ali Bijani
Journal:  Caspian J Intern Med       Date:  2021-04

6.  Evaluation of regional ventilation by electric impedance tomography during percutaneous dilatational tracheostomy in neurocritical care: a pilot study.

Authors:  Vera Spatenkova; Eckhard Teschner; Jaroslav Jedlicka
Journal:  BMC Neurol       Date:  2020-10-12       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.